Bosentan attenuates sickle cell disease erythrocyte HbS polymerization and impaired deformability induced by endothelin-1
Canadian Journal of Physiology and Pharmacology · 01.12.2023 · 101 (12) · 642-651
DOI: 10.1139/cjpp-2022-0012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Journal of Physiology and Pharmacology, erschienen am 01.12.2023. Verfasst von Lyzes Rosa Teixeira-Alves und 4 weiteren Autor:innen. Beteiligte Einrichtung: Grupo de Pesquisa em Fisiologia Eritróide-GPFisEri, Universidade Federal do Rio de Janeiro, Campus Macaé, Brazil. Hauptthemen laut MEDLINE: Endothelin-1, Anemia, Sickle Cell. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro.
Abstract (Originalsprache)
The effects of endothelin-1 (ET-1) on erythrocytes from sickle cell disease (SCD) patients have been described, but mechanisms of ET-1 regarding primary erythrocyte functions remain unknown. ET-1 is a vasoconstrictor peptide produced by endothelial cells, and the expression of ET-1 is increased in SCD. The present study used ex vivo experiments with sickle cell erythrocytes, ET-1, and bosentan, a dual antagonist of ET A and ET B receptors. We performed a hemoglobin S (HbS) polymerization assay with three concentrations of ET-1 (1, 20, and 50 pg/mL) and bosentan (100 nmol/L). ET-1 increased HbS polymerization at all concentrations, and this effect was suppressed by bosentan. For the deformability assay, red blood cells (RBCs) were incubated on a Sephacryl column with the same concentrations of ET-1 and bosentan. ET-1 decreased deformability, and this effect was reversed by bosentan. To observe erythrocyte adhesion, ET-1 and bosentan were incubated with RBCs in thrombospondin-coated 96-well plate, which demonstrated that ET-1 decreased adhesion but that bosentan enhanced adhesion. We also assessed erythrocyte apoptosis and observed decreased eryptosis induced by ET-1, and these effects were inhibited bosentan. Thus, these findings demonstrated that ET-1 modulates HbS polymerization, erythrocyte deformability, adhesion to thrombospondin, and eryptosis, and these effects were suppressed or enhanced by bosentan.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Grupo de Pesquisa em Fisiologia Eritróide-GPFisEri, Universidade Federal do Rio de Janeiro, Campus Macaé, Brazil.
- Programa de Pós-graduação em Endocrinologia, Faculdade de Medicina, Universidade Federal do Rio de Janeiro, Brazil.
- Laboratório de Endocrinologia Experimental-LEEx, Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Brazil.
- Programa de Pós-graduação em Farmacologia e Química Medicinal, Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Brazil.
- Faculdade de Farmácia, Universidade Federal do Rio de Janeiro, Campus Macaé, Brazil.
ORCID-Profile: Clemilson Berto-Junior
Förderung
- Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
Zitieren
APA
Rosa Teixeira-Alves, L., Guimarães-Nobre, C. C., Mendonça-Reis, E., Miranda-Alves, L., & Berto-Junior, C. (2023). Bosentan attenuates sickle cell disease erythrocyte HbS polymerization and impaired deformability induced by endothelin-1. Canadian Journal of Physiology and Pharmacology, 101(12), 642-651. https://doi.org/10.1139/cjpp-2022-0012
Vancouver
Rosa Teixeira-Alves L, Guimarães-Nobre CC, Mendonça-Reis E, Miranda-Alves L, Berto-Junior C. Bosentan attenuates sickle cell disease erythrocyte HbS polymerization and impaired deformability induced by endothelin-1. Canadian Journal of Physiology and Pharmacology. 2023;101(12):642-651. doi:10.1139/cjpp-2022-0012
BibTeX
@article{RosaTeixeiraAlves2023,
author = {Rosa Teixeira-Alves, Lyzes and Guimarães-Nobre, Camila Cristina and Mendonça-Reis, Evelyn and Miranda-Alves, Leandro and Berto-Junior, Clemilson},
title = {Bosentan attenuates sickle cell disease erythrocyte HbS polymerization and impaired deformability induced by endothelin-1},
journal = {Canadian Journal of Physiology and Pharmacology},
year = {2023},
volume = {101},
number = {12},
pages = {642--651},
doi = {10.1139/cjpp-2022-0012}
}
EUVIMED